Free Trial
NYSE:ZTS

Zoetis Q2 2025 Earnings Report

Zoetis logo
$147.40 +1.61 (+1.10%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$147.36 -0.03 (-0.02%)
As of 08/1/2025 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zoetis EPS Results

Actual EPS
N/A
Consensus EPS
$1.61
Beat/Miss
N/A
One Year Ago EPS
N/A

Zoetis Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.41 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Zoetis Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 5, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Zoetis Earnings Headlines

Rep. Jefferson Shreve Sells Zoetis Inc. (NYSE:ZTS) Stock
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Market Whales and Their Recent Bets on ZTS Options
See More Zoetis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Zoetis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zoetis and other key companies, straight to your email.

About Zoetis

Zoetis (NYSE:ZTS) engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

View Zoetis Profile

More Earnings Resources from MarketBeat